You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-muscle

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

Not yet recruiting
  • High-risk Non-muscle Invasive Bladder Cancer
  • (no location specified)
Oct 25, 2023

Non-muscle Invasive Bladder Cancer Trial in Chengdu (RC48-ADC)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • Chengdu, Sichuan, China
    West China Hospital
Aug 10, 2023

Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
    • (no location specified)
    Apr 11, 2023

    Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

    Completed
    • Urinary Bladder Cancer
    • +4 more
    • Neutrophil to lymphocyte ratio
    • Cairo, Egypt
      Ain Shams university
    Jul 15, 2023

    Non-muscle Invasive Bladder Cancer Trial (TARA-002)

    Not yet recruiting
    • Non-muscle Invasive Bladder Cancer
    • TARA-002
    • (no location specified)
    Jul 14, 2023

    Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

    Recruiting
    • Non Muscle Invasive Bladder Cancer
    • N803 plus Bacillus Calmette-Guerin (BCG)
    • Honolulu, Hawaii
      Island Urology
    Aug 7, 2023

    Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

    Not yet recruiting
    • Non-Muscle- Invasive Bladder Cancer
    • Durvalumab
    • BCG
    • (no location specified)
    Jul 5, 2023

    Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)

    Recruiting
    • Bladder Cancer
    • Pseudomonas aeruginosa
    • Jinan, Shandong, China
      Qilu hospital
    Jul 26, 2023

    Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder

    Not yet recruiting
    • Non-muscle-invasive Bladder Cancer
    • +2 more
    • PDD-TURBT with hexaminolevulinate (Hexvix®)
    • Power Led Saphira (TM) from KARL STORZ
    • (no location specified)
    Jul 24, 2023

    BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder

    Recruiting
    • Bladder Cancer
      • Little Rock, Arkansas
      • +2 more
      Aug 6, 2023

      Uromonitor asBiomarker for Optimization of NMIBC Management by

      Not yet recruiting
      • Non-muscle-invasive Bladder Cancer
        • (no location specified)
        May 9, 2023

        Non-muscle-invasive Bladder Cancer Trial (Cystoscopy, Bladder EpiCheck urine test, Xpert Bladder Cancer Monitor urine test)

        Not yet recruiting
        • Non-muscle-invasive Bladder Cancer
        • Cystoscopy
        • +2 more
        • (no location specified)
        Apr 4, 2023

        Mood Alterations in Non-Muscle Invasive Bladder Cancer Treated

        Recruiting
        • Non-Muscle Invasive Bladder Cancer
        • Questionnaires
        • +4 more
        • Washington, District of Columbia
          Sibley Memorial Hospital
        Jan 17, 2023

        Non-Muscle Invasive Bladder Cancer, Self Efficacy, Smoking Behaviors Trial in Istanbul (Behavioral: Motivational Interviewing

        Not yet recruiting
        • Non-Muscle Invasive Bladder Cancer
        • +4 more
        • Behavioral: Motivational Interviewing with WhatsApp video call
        • Istanbul, Turkey
          İrem Nur Ozdemir
        Jan 20, 2023

        Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)

        Active, not recruiting
        • Non-muscle-invasive Bladder Cancer
        • Gemcitabine 1000 mg, Docetaxel 37.5g
        • Zagreb, Croatia
          University Hospital Centre Zagreb
        Jan 20, 2023

        Analytical Specificity of Bladder EpiCheck Test in Healthy

        Completed
        • Non Muscle Invasive Bladder Cancer
        • Non-Muscle Invasive Bladder Urothelial Carcinoma
        • Bladder EpiCheck
        • San Antonio, Texas
          Urology San Antonio
        Sep 3, 2023

        Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer Trial (Cretostimogene Grenadenorepvec,

        Not yet recruiting
        • Non Muscle Invasive Bladder Cancer
        • +3 more
        • Cretostimogene Grenadenorepvec
        • n-dodecyl-B-D-maltoside
        • (no location specified)
        Oct 30, 2023

        Bladder Cancer Trial in Roskilde (Urine test)

        Recruiting
        • Bladder Cancer
          • Roskilde, Denmark
            Zealand University Hospital
          Oct 5, 2022

          Non-muscle Invasive Bladder Cancer (NMIBC) Trial in Rozzano (Hyaluronic Acid (HA) sodium salt and Hydeal-D)

          Terminated
          • Non-muscle Invasive Bladder Cancer (NMIBC)
          • Hyaluronic Acid (HA) sodium salt and Hydeal-D
          • Rozzano, Mi, Italy
            Humanitas Research Hospital
          Sep 29, 2023

          Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)

          Recruiting
          • Non-muscle-invasive Bladder Cancer
          • Cairo, Egypt
            Mohamed Fawzy Salman
          Nov 19, 2022

          Non-Muscle Invasive Bladder Cancer Trial in Aarhus (Laser ablation)

          Recruiting
          • Non-Muscle Invasive Bladder Cancer
          • Laser ablation
          • Aarhus, Denmark
            Aarhus University Hospital
          Aug 5, 2022

          Bladder Cancer, Non-muscle Invasive Trial in Biel (Epirubicin, Mitomycin, Gemcitabine)

          Recruiting
          • Bladder Cancer
          • Non-muscle Invasive
          • Biel, Switzerland
            Roland Seiler
          Nov 17, 2022

          Non-Muscle Invasive Bladder Cancer, HER2 Trial (RC48, Tislelizumab)

          Not yet recruiting
          • Non-Muscle Invasive Bladder Cancer
          • HER2
          • (no location specified)
          Jul 16, 2023

          Non-muscle-invasive Bladder Cancer Trial in Shanghai (BCG combined with Tislelizumab)

          Not yet recruiting
          • Non-muscle-invasive Bladder Cancer
          • BCG combined with Tislelizumab
          • Shanghai, Shanghai, China
            Ruijin Hospital, Shanghai Jiaotong University School of Medicine
          Oct 12, 2022

          Non-muscle Invasive Bladder Cancer Trial (TARA-002)

          Not yet recruiting
          • Non-muscle Invasive Bladder Cancer
          • TARA-002
          • (no location specified)
          Aug 24, 2022